Showing results (181-190 of 296) with videos related to
Sort By:
Pageof 30
Archives of Internal Medicine|October 20, 1998
Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension. ISHIB Investigators Group. International Society on Hypertension in BlacksW D Hall, J W Reed, J M Flack, et al.American Journal of Hypertension|July 1, 1993
Chlorthalidone attenuates the reduction in total cholesterol and small, dense LDL cholesterol subclass associated with weight lossK Bradley, J M Flack, J Belcher, et al.Journal of Lipid Research|February 1, 1991
A micro-enzymatic method to measure cholesterol and triglyceride in lipoprotein subfractions separated by density gradient ultracentrifugation from 200 microliters of plasma or serumJ D Belcher, J O Egan, G Bridgman, et al.The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregationP Li, M Fukuhara, D I Diz, et al.Angiology|August 1, 1995
Angiotensin II pressor activity depends on medial and lateral anterior hypothalamic pathwaysH Kawabe, O U Lopes, K B Brosnihan, et al.The American Journal of Physiology|June 1, 1984
Assessment of parasympathetic control of heart rate by a noninvasive methodF M Fouad, R C Tarazi, C M Ferrario, et al.Clinical Cardiology|August 1, 1991
Hypertensive mechanisms and converting enzyme inhibitorsC M Ferrario, N Jaiswal, K Yamamoto, et al.Hypertension (Dallas, Tex. : 1979)|September 18, 1998
Converting enzyme determines plasma clearance of angiotensin-(1-7)K Yamada, S N Iyer, M C Chappell, et al.Hypertension (Dallas, Tex. : 1979)|August 1, 1992
Tissue renin-angiotensin systems in renal hypertensionM Nishimura, A Milsted, C H Block, et al.Neuroendocrinology|May 1, 1984
Restricted dietary sodium intake alters peripheral but not central angiotensin II receptorsR C Speth, R Singh, R R Smeby, et al.Pageof 30